Sort by
Items per page

Send to

Choose Destination

Search results

Items: 29


Genetic modifiers of muscular dystrophy act on sarcolemmal resealing and recovery from injury.

Quattrocelli M, Capote J, Ohiri JC, Warner JL, Vo AH, Earley JU, Hadhazy M, Demonbreun AR, Spencer MJ, McNally EM.

PLoS Genet. 2017 Oct 24;13(10):e1007070. doi: 10.1371/journal.pgen.1007070. eCollection 2017 Oct.


Experimental Modeling Supports a Role for MyBP-HL as a Novel Myofilament Component in Arrhythmia and Dilated Cardiomyopathy.

Barefield DY, Puckelwartz MJ, Kim EY, Wilsbacher LD, Vo AH, Waters EA, Earley JU, Hadhazy M, Dellefave-Castillo L, Pesce LL, McNally EM.

Circulation. 2017 Oct 17;136(16):1477-1491. doi: 10.1161/CIRCULATIONAHA.117.028585. Epub 2017 Aug 4.


Intermittent glucocorticoid steroid dosing enhances muscle repair without eliciting muscle atrophy.

Quattrocelli M, Barefield DY, Warner JL, Vo AH, Hadhazy M, Earley JU, Demonbreun AR, McNally EM.

J Clin Invest. 2017 Jun 1;127(6):2418-2432. doi: 10.1172/JCI91445. Epub 2017 May 8.


Overexpression of Latent TGFβ Binding Protein 4 in Muscle Ameliorates Muscular Dystrophy through Myostatin and TGFβ.

Lamar KM, Bogdanovich S, Gardner BB, Gao QQ, Miller T, Earley JU, Hadhazy M, Vo AH, Wren L, Molkentin JD, McNally EM.

PLoS Genet. 2016 May 5;12(5):e1006019. doi: 10.1371/journal.pgen.1006019. eCollection 2016 May.


Enhanced Muscular Dystrophy from Loss of Dysferlin Is Accompanied by Impaired Annexin A6 Translocation after Sarcolemmal Disruption.

Demonbreun AR, Allen MV, Warner JL, Barefield DY, Krishnan S, Swanson KE, Earley JU, McNally EM.

Am J Pathol. 2016 Jun;186(6):1610-22. doi: 10.1016/j.ajpath.2016.02.005. Epub 2016 Apr 9.


Reengineering a transmembrane protein to treat muscular dystrophy using exon skipping.

Gao QQ, Wyatt E, Goldstein JA, LoPresti P, Castillo LM, Gazda A, Petrossian N, Earley JU, Hadhazy M, Barefield DY, Demonbreun AR, Bönnemann C, Wolf M, McNally EM.

J Clin Invest. 2015 Nov 2;125(11):4186-95. doi: 10.1172/JCI82768. Epub 2015 Oct 12.


Eps 15 Homology Domain (EHD)-1 Remodels Transverse Tubules in Skeletal Muscle.

Demonbreun AR, Swanson KE, Rossi AE, Deveaux HK, Earley JU, Allen MV, Arya P, Bhattacharyya S, Band H, Pytel P, McNally EM.

PLoS One. 2015 Sep 1;10(9):e0136679. doi: 10.1371/journal.pone.0136679. eCollection 2015.


Targeting latent TGFβ release in muscular dystrophy.

Ceco E, Bogdanovich S, Gardner B, Miller T, DeJesus A, Earley JU, Hadhazy M, Smith LR, Barton ER, Molkentin JD, McNally EM.

Sci Transl Med. 2014 Oct 22;6(259):259ra144. doi: 10.1126/scitranslmed.3010018.


FOG-2 mediated recruitment of the NuRD complex regulates cardiomyocyte proliferation during heart development.

Garnatz AS, Gao Z, Broman M, Martens S, Earley JU, Svensson EC.

Dev Biol. 2014 Nov 1;395(1):50-61. doi: 10.1016/j.ydbio.2014.08.030. Epub 2014 Sep 6.


Excess SMAD signaling contributes to heart and muscle dysfunction in muscular dystrophy.

Goldstein JA, Bogdanovich S, Beiriger A, Wren LM, Rossi AE, Gao QQ, Gardner BB, Earley JU, Molkentin JD, McNally EM.

Hum Mol Genet. 2014 Dec 20;23(25):6722-31. doi: 10.1093/hmg/ddu390. Epub 2014 Jul 28.


Abcc9 is required for the transition to oxidative metabolism in the newborn heart.

Fahrenbach JP, Stoller D, Kim G, Aggarwal N, Yerokun B, Earley JU, Hadhazy M, Shi NQ, Makielski JC, McNally EM.

FASEB J. 2014 Jul;28(7):2804-15. doi: 10.1096/fj.13-244459. Epub 2014 Mar 19.


EHD1 mediates vesicle trafficking required for normal muscle growth and transverse tubule development.

Posey AD Jr, Swanson KE, Alvarez MG, Krishnan S, Earley JU, Band H, Pytel P, McNally EM, Demonbreun AR.

Dev Biol. 2014 Mar 15;387(2):179-90. doi: 10.1016/j.ydbio.2014.01.004. Epub 2014 Jan 17.


Dysferlin and myoferlin regulate transverse tubule formation and glycerol sensitivity.

Demonbreun AR, Rossi AE, Alvarez MG, Swanson KE, Deveaux HK, Earley JU, Hadhazy M, Vohra R, Walter GA, Pytel P, McNally EM.

Am J Pathol. 2014 Jan;184(1):248-59. doi: 10.1016/j.ajpath.2013.09.009. Epub 2013 Oct 29.


SMAD signaling drives heart and muscle dysfunction in a Drosophila model of muscular dystrophy.

Goldstein JA, Kelly SM, LoPresti PP, Heydemann A, Earley JU, Ferguson EL, Wolf MJ, McNally EM.

Hum Mol Genet. 2011 Mar 1;20(5):894-904. doi: 10.1093/hmg/ddq528. Epub 2010 Dec 6.


Impaired muscle growth and response to insulin-like growth factor 1 in dysferlin-mediated muscular dystrophy.

Demonbreun AR, Fahrenbach JP, Deveaux K, Earley JU, Pytel P, McNally EM.

Hum Mol Genet. 2011 Feb 15;20(4):779-89. doi: 10.1093/hmg/ddq522. Epub 2010 Dec 1.


Ets1 is required for proper migration and differentiation of the cardiac neural crest.

Gao Z, Kim GH, Mackinnon AC, Flagg AE, Bassett B, Earley JU, Svensson EC.

Development. 2010 May;137(9):1543-51. doi: 10.1242/dev.047696. Epub 2010 Mar 31.


Myoferlin is required for insulin-like growth factor response and muscle growth.

Demonbreun AR, Posey AD, Heretis K, Swaggart KA, Earley JU, Pytel P, McNally EM.

FASEB J. 2010 Apr;24(4):1284-95. doi: 10.1096/fj.09-136309. Epub 2009 Dec 11.


Nesprin-1 mutations in human and murine cardiomyopathy.

Puckelwartz MJ, Kessler EJ, Kim G, Dewitt MM, Zhang Y, Earley JU, Depreux FF, Holaska J, Mewborn SK, Pytel P, McNally EM.

J Mol Cell Cardiol. 2010 Apr;48(4):600-8. doi: 10.1016/j.yjmcc.2009.11.006. Epub 2009 Nov 24.


Impaired exercise tolerance and skeletal muscle myopathy in sulfonylurea receptor-2 mutant mice.

Stoller D, Pytel P, Katz S, Earley JU, Collins K, Metcalfe J, Lang RM, McNally EM.

Am J Physiol Regul Integr Comp Physiol. 2009 Oct;297(4):R1144-53. doi: 10.1152/ajpregu.00081.2009. Epub 2009 Aug 12.


Translational control of FOG-2 expression in cardiomyocytes by microRNA-130a.

Kim GH, Samant SA, Earley JU, Svensson EC.

PLoS One. 2009 Jul 7;4(7):e6161. doi: 10.1371/journal.pone.0006161.


Disruption of nesprin-1 produces an Emery Dreifuss muscular dystrophy-like phenotype in mice.

Puckelwartz MJ, Kessler E, Zhang Y, Hodzic D, Randles KN, Morris G, Earley JU, Hadhazy M, Holaska JM, Mewborn SK, Pytel P, McNally EM.

Hum Mol Genet. 2009 Feb 15;18(4):607-20. doi: 10.1093/hmg/ddn386. Epub 2008 Nov 13.


Reduced life span with heart and muscle dysfunction in Drosophila sarcoglycan mutants.

Allikian MJ, Bhabha G, Dospoy P, Heydemann A, Ryder P, Earley JU, Wolf MJ, Rockman HA, McNally EM.

Hum Mol Genet. 2007 Dec 1;16(23):2933-43. Epub 2007 Sep 12.


Mice lacking sulfonylurea receptor 2 (SUR2) ATP-sensitive potassium channels are resistant to acute cardiovascular stress.

Stoller D, Kakkar R, Smelley M, Chalupsky K, Earley JU, Shi NQ, Makielski JC, McNally EM.

J Mol Cell Cardiol. 2007 Oct;43(4):445-54. Epub 2007 Aug 1.


FOG-2 attenuates endothelial-to-mesenchymal transformation in the endocardial cushions of the developing heart.

Flagg AE, Earley JU, Svensson EC.

Dev Biol. 2007 Apr 1;304(1):308-16. Epub 2006 Dec 21.


Nuclear sequestration of delta-sarcoglycan disrupts the nuclear localization of lamin A/C and emerin in cardiomyocytes.

Heydemann A, Demonbreun A, Hadhazy M, Earley JU, McNally EM.

Hum Mol Genet. 2007 Feb 15;16(4):355-63. Epub 2006 Dec 12.


Fog1 is required for cardiac looping in zebrafish.

Walton RZ, Bruce AE, Olivey HE, Najib K, Johnson V, Earley JU, Ho RK, Svensson EC.

Dev Biol. 2006 Jan 15;289(2):482-93. Epub 2005 Nov 28.


Normal myoblast fusion requires myoferlin.

Doherty KR, Cave A, Davis DB, Delmonte AJ, Posey A, Earley JU, Hadhazy M, McNally EM.

Development. 2005 Dec;132(24):5565-75. Epub 2005 Nov 9.


Transplanted hematopoietic stem cells demonstrate impaired sarcoglycan expression after engraftment into cardiac and skeletal muscle.

Lapidos KA, Chen YE, Earley JU, Heydemann A, Huber JM, Chien M, Ma A, McNally EM.

J Clin Invest. 2004 Dec;114(11):1577-85.


Secondary coronary artery vasospasm promotes cardiomyopathy progression.

Wheeler MT, Korcarz CE, Collins KA, Lapidos KA, Hack AA, Lyons MR, Zarnegar S, Earley JU, Lang RM, McNally EM.

Am J Pathol. 2004 Mar;164(3):1063-71.

Supplemental Content

Loading ...
Support Center